fbpx
(561) 802-3060 info@mri-news.com

FDA Approves Dexcom G5 for Insulin Dosing

Users of the Dexcom G5 Mobile Continuous Glucose Monitoring System (Dexcom G5) can now rely on the device to make diabetes treatment decisions using two finger pricks daily, not multiple ones, following the U.S. Food and Drug Administration’s (FDA) approval of expanded use of the device.

On Tuesday, the FDA granted the expanded indication. Users must still calibrate the device at least two times a day by testing a fingertip blood sample with a blood glucose meter.


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


Clinical Advances in Type 1 Diabetes

Clinical Advances in Type 1 Diabetes

Learn about the latest clinical advances in managing blood sugars in Type 1 Diabetes.

Clinical study enrolling now!

To learn more call Metabolic Research Institute (561) 802-3060 or visit: http://mri-news.com/dm1-on-lantus/

 


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


 

 

Type 2 Diabetes – Clinical Study Enrolling Now

Type 2 Diabetes – Clinical Study Enrolling Now

Learn more about the new investigational drug for blood sugar control with Type 2 Diabetes.

Clinical study enrolling now: http://mri-news.com/type-2-diabetes-clinical-trial/

 


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


 

November is National Diabetes Month

November is National Diabetes Month

This is National Diabetes Month . . connect with your community for better health.

Our mission at the Metabolic Research Institute in West Palm Beach, Florida is to provide our patients and sponsors with the highest quality of clinical diabetes research available in today’s medical professional environment. We are committed to delivering efficient and timely research data, while focusing on strict adherence to protocol guidelines.

Today, we have better approaches in treating diabetes & other endocrine disorders. Why?  Because people like you took part in a clinical research trial.

We enroll adult volunteers in clinical research studies in the following areas:

• Type 1 Diabetes
• Type 2 Diabetes
•      Hypertension
•      High Cholesterol and/or Triglycerides
• Kidney Disease (Nephropathy)
•      Peripheral Neuropathy
•      Weight loss

The benefits of participating include study medication, examinations, and laboratory tests, all at no expense to you. In addition, some clinical trials reimburse participants for time and travel.

For more information, talk with your doctor, or call: (561) 802-3060, ext. 8036


NIH statement from Dr. Griffin P. Rodgers, Director, National Institute of Diabetes and Digestive and Kidney Diseases.

For many millions of Americans, diabetes is a lifelong burden. But it does not have to be a lifelong barrier to better health. This National Diabetes Month, the National Institutes of Health encourages people with diabetes and those who care for them to find the support they need, and for all people to gain understanding and offer support to those with this challenging disease.

Diabetes takes multiple forms. In type 1 diabetes, the body does not make insulin. In type 2 diabetes, the most common type, the body does not make enough insulin or it does not use insulin well. Both types can lead to heart, kidney, nerve, and eye diseases.

But people are not powerless when it comes to management of diabetes. Research led by NIH has shown that working to control blood glucose, or blood sugar, can have a lifelong effect on health, dramatically lowering the risk of many complications of diabetes.

NIH’s National Institute of Diabetes and Digestive and Kidney Diseases remains at the forefront of pivotal research to prevent, treat and, one day, cure all types of diabetes, for everyone.

As President Barack Obama states in his Proclamation (link is external), if you have diabetes, or care for someone with the disease, you are not alone. Building a support network can help you stay healthy. And supporting a person with diabetes can start small. Ask your loved one to show you how he or she is managing the disease. What goals have been set?  What gets in the way of reaching goals? How can you help?

For people with diabetes, managing the disease is a balancing act, and your needs can change over time. Caring for your health is a matter of trying and learning what works best for you. Family, friends, health care professionals, and communities all belong on your team.

More information on diabetes is available through the NIDDK and the National Diabetes Education Program, a joint program of NIH and the Centers for Disease Control and Prevention.

The NIDDK, part of the NIH, conducts and supports basic and clinical research and research training on some of the most common, severe, and disabling conditions affecting Americans. The Institute’s research interests include: diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. For more information, visit www.niddk.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


 

Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


 

Your Good Health Is Our Mission

Your Good Health Is Our Mission

Millions of Americans walk around with undetected chronic diseases, not realizing that if they took advantage of preventative screening tests, their risk of developing serious complications could be limited.

Your age, health and family history, lifestyle choices (i.e. what you eat, how active you are, whether you smoke), and other important factors can impact what type of, and how often you need, health care.

From High Blood Pressure to Cholesterol levels, your wellness matters to us.

Know Your Numbers!

Metabolic Research Institute, Inc. offers complimentary health screenings to the public, including:
• Blood pressure check
• Fasting blood sugar test
• Routine urinalysis
• BMI calculation
• Height & weight

No medical referral is needed, and health insurance is not required. An appointment is necessary.

For more information, or to schedule an appointment, please go to: http://mri-news.com/complimentary-health-screenings/

 


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


 

Understanding the Difference Between Type I and Type II Diabetes

Understanding the Difference Between Type I and Type II Diabetes

At the Metabolic Research Institute, our areas of focus and study range from growth disorders to diabetes. We focus many of our studies on testing and researching different options for a diabetes treatment. While many people are familiar with diabetes, or have at least heard the term, many do not understand the differences between the two different types of diabetes.

People who suffer from diabetes experience a number of difficulties and can even develop different diseases as a side effect. There are two distinct types of diabetes and each type should be approached differently.

  • Type I diabetes is typically diagnosed in children and young adults. According to the American Diabetes Association, only about 5% of people with diabetes suffer from type I. With type I diabetes, the body does not produce insulin. Insulin is an important hormone we need to convert sugar, starches, and other food into energy. This can be very dangerous however, people can manage this with insulin therapy. This allows people with type I diabetes to process the food they eat and live healthy lives. Type II- Type II diabetes is the most common form of diabetes.
  • Type II diabetes causes one’s blood glucose level to rise higher than normal. The body still produces insulin however, it does not use properly. The American Diabetes Association identifies this as “insulin resistance.” This means that the body produces extra insulin to make up for the resistance however, eventually the body cannot make enough insulin to keep up with the rising levels. Like type I, type II can be treated with insulin therapy, as well as oral medications and lifestyle changes.

At the Metabolic Research Institute, we are dedicated to searching for different, more effective treatment options for both types of diabetes. We want to help people live happier, healthier lives without being held back by their diseases or ailments. If you are interested in participating in clinical studies and helping us fight these diseases, please contact us today!


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.